A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic.
On-Demand Webinar: Fragment-Based Ligand Discovery
Learn how biophysical and structural biology methods enable the rapid identification, characterization, and optimization of hit fragments.
Publication: Control of Antitumor Activity and Specificity of CAR T Cells
Learn how the tumor-targeting specificity and activity of T cells with a CAR can be regulated by the concentration of a small-molecule adapter.
On-Demand Webinar: AAV Gene Therapy Discovery and Optimization
Learn how WuXi AppTec can support project teams during the discovery stages of a viral gene therapy program.
Publication: Design of Potent and Selective KRAS G12D Inhibitors
A structure-based drug discovery approach was used to design and optimize a series of potent and selective KRAS G12D inhibitors.
Poster: Inhibition of KRAS G12C and PD1 Boosts Therapeutic Efficacy
Combination therapy resulted in significant anti-tumor activities in humanized NSCLC mouse models via conditioning of the tumor microenvironment
White Paper: Oligonucleotide Therapeutics
Oligonucleotide Drug Discovery Through Tightly Coupled Chemistry and Biology
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by more than 2,800 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.Speak with a Specialist
Customized hit identification and screening solutions to enable rapid drug discovery success.
Integrated Drug Discovery
Expertise in synthetic and medicinal chemistry, biology, DMPK and program management for drug discovery.
Integrated Drug Discovery
A full spectrum of biology services and solutions from target discovery to candidate selection and into the clinic.
High quality integrated analytical services in a rapid & cost effective manner
Target Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Parallel Purification of High-Quality Therapeutic TargetsVIEW Poster
Negative allosteric modulation of the µ-opioid receptorVIEW Publication
ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorVIEW Publication